In summary, here, we provide evidence of a neuroprotective effect of the pharmacological inhibition of C5a-C5aR1 signaling in the pathology progression in the Tg2576 mouse model of Alzheimer’s disease. The gene discussed is C5AR1; the disease is early-onset autosomal dominant Alzheimer disease.